Evogene Ltd. (NASDAQ:EVGN) Q1 2026 Earnings Call Transcript
Operator: Welcome to Evogene's First Quarter 2026 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded May 20, 2026.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 50,526 | $21,383 | 0% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.60 | 1,129 | $677.40 | 1,129 | 2026-06-04 | Filing | |
| $0.64 | 460,000 | $292,100.00 | 1,343,886 | 2026-08-11 | Filing | |
| $0.50 | 800,000 | $400,000.00 | 883,886 | 2026-08-04 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 80,078 | $33,889 | 0% | |
| 2. | 19,404 | $8,212 | 0% | |
| 3. | 10,790 | $4,737 | 0% | |
| 4. | 9,253 | $4,651 | 0% | |
| 5. | 2,830 | $1,242 | 0% |